Summary of Canopy Growth Corporation 2021 Annual General and Special Meeting of Shareholders Company Overview - **Company**: Canopy Growth Corporation (NASDAQ: CGC) - **Date of Meeting**: September 14, 2021 Key Points Discussed Industry Context - The cannabis industry, including Canadian licensed producers and U.S. multistate operators, has experienced a downturn in share prices over recent months, attributed to concerns regarding federal permissibility in the U.S. [20] Financial Performance - Canopy Growth presented its audited consolidated financial statements for the fiscal year ending March 31, 2021, and the previous three years. [8] - The company anticipates achieving profitability on a quarterly basis by the end of the current fiscal year, driven by revenue growth and cost management. [26] Innovation and Product Development - Canopy Growth is focusing on leveraging R&D capabilities to bring differentiated products to market, with plans to deliver over 100 SKUs in fiscal 2022. [17] - The company launched the Whisl CBD vape in the U.S., targeting various consumer needs such as focus, calm, and relaxation. [18] Growth Opportunities - The company is preparing to enter the U.S. market through investments in Acreage and TerrAscend, alongside its CBD brands like Quatreau and Whisl. [21] - Canopy Growth holds a 35% dollar share of the total THC beverage category in Canada, indicating strong performance in this segment. [23] Consumer Trends - There is a growing consumer preference for higher THC beverages, particularly those with 5 to 10 milligrams of THC per serving. [24] Shareholder Engagement - No shareholder questions were submitted regarding the proposals during the meeting, indicating a lack of immediate concerns from shareholders. [11] Future Outlook - The company remains optimistic about its growth trajectory and the introduction of new products, aiming to create significant shareholder value. [21][28] Additional Important Information - The meeting was conducted virtually, and all proposals presented were passed unanimously. [13] - The company emphasized the importance of understanding consumer behavior to inform its innovation strategy. [17] - Canopy Growth's management team, including CEO David Klein, expressed confidence in the company's ability to navigate current market challenges and capitalize on future opportunities. [26][28]

Financial Data and Key Metrics Changes - Canopy Growth has made significant progress in transforming its business over the past 18 months, focusing on three core markets: Canada, the U.S., and Germany, which represent over 95% of the total addressable market [5] - The SG&A expenses have been reduced from 135% of sales in Q1 of fiscal 2020 to 68% in Q1 of fiscal 2022, with expectations for further reductions [5][6] - CapEx has declined significantly to $20 million last quarter, although this should not be viewed as a quarterly run rate for fiscal 2022 [6] Business Line Data and Key Metrics Changes - Net revenue for the Canadian recreational cannabis business grew 36% year-over-year in Q1 fiscal 2022 [8] - Storz & Bickel, the premium vaporizer business, delivered 41% growth, while BioSteel, the sports nutrition brand, achieved 179% growth year-over-year [8] - U.S. operations generated $65 million in revenue in FY 2021, with Q1 2022 U.S. revenues increasing 91% year-over-year, accounting for 15% of total sales [9] Market Data and Key Metrics Changes - The legal Canadian THC market is expected to reach CAD$7.5 billion by 2023, while the U.S. CPG and CBD businesses could tap into a combined $33 billion market [8] - The German THC and dronabinol markets could exceed $2 billion, with the U.S. THC market potentially adding another $40 billion when federally permissible [8] Company Strategy and Development Direction - The company is focused on building a significant ecosystem in the U.S. ahead of expected cannabis reform, with a strong emphasis on social justice and equity commitments [4][20] - Canopy Growth aims to capitalize on growth opportunities in its core markets while preparing to enter the U.S. THC market [8][10] - The innovation pipeline is set to deliver over 100 SKUs over the remainder of fiscal 2022, with a focus on mood management products [7] Management's Comments on Operating Environment and Future Outlook - Management believes momentum is building across the business, with significant growth expected in the second half of fiscal 2022 [4] - The Canadian market is expected to grow 40% this year, primarily driven by existing consumers shifting from the illicit market to legal purchases [34] - Management remains optimistic about cannabis reform in the U.S., citing strong public support for legalization [20][21] Other Important Information - Canopy Growth has partnered with National Expungement Works to support social justice initiatives related to cannabis prohibition [24] - The company is actively seeking additional federally legal investments to increase exposure to the U.S. THC market [20] Q&A Session Summary Question: What types of opportunities is Canopy looking at to increase U.S. THC exposure? - Canopy has a path to owning 70% of Acreage, which is well-positioned in east coast markets, and is also interested in brands and capabilities in states like California [26][27] Question: What are the biggest learnings from launching new CBD brands like Martha and Quatreau? - There is significant consumer interest in stress reduction and wellness, with many consumers entering the CBD category through credible brands like Martha Stewart [29][30] Question: What is the state of the Canadian business as it emerges from the pandemic? - The Canadian market is expected to grow 40% this year, with improvements in access and supply chain challenges being addressed [33][34]

Canopy Growth Corporation (NASDAQ:CGC) Q1 2022 Earnings Conference Call August 6, 2021 10:00 AM ET Company Participants Judy Hong - VP, IR David Klein - CEO Michael Lee - CFO Conference Call Participants Heather Balsky - Bank of America Doug Miehm - RBC Capital Market Tamy Chen - BMO Capital Markets Andrew Carter - Stifel Bill Kirk - MKM Partners John Zamparo - CIBC Michael Lavery - Piper Sandler Adam Buckham - Scotiabank Rupesh Parikh - Oppenheimer Operator Good morning. My name is Michelle, and I will be ...

CANOPY GROWTH Q1 2022 EARNINGS PRESENTATION August 6, 2021 DISCLAIMERS AND CAUTIONARY STATEMENTS 2 This presentation contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common shares, no par value CGC NASDAQ Global Select Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Nu ...

Canopy Growth Corp. (NASDAQ:CGC) Q4 2021 Results Conference Call June 1, 2021 10:00 AM ET Company Participants Judy Hong - Vice President, Investor Relations David Klein - Chief Executive Officer Michael Lee - Chief Financial Officer Conference Call Participants Heather Balsky - Bank of America Adam Buckham - Scotiabank Vivien Azer - Cowen and Company Graeme Kreindler - Eight Capital Rupesh Parikh - Oppenheimer Michael Lavery - Piper Sandler Aaron Grey - Alliance Global Glenn Mattson - Ladenburg Thalman ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38496 | --- | --- | |--------------------------------------------------------------------------------------------------|---------------- ...

The Supreme Cannabis Company, Inc. (SPRWF) Q3 2021 Results Conference Call May 14, 2021 8:00 AM ET Company Participants Beena Goldenberg - President and Chief Executive Officer Nikhil Handa - Chief Financial Officer Conference Call Participants Andrew Partheniou - Stifel Operator Good morning everyone. Welcome to The Supreme Cannabis Company Third Quarter Fiscal 2021 Results Conference Call. Listeners are reminded that certain matters discussed in today's conference call or answers that may be given to ques ...

CANOPY GROWTH CORPORATION !"#$ %&'()*+*&, -".,(/&) 012&+3*415&'6."4"781-".#&)&.'& !"#$%&'())*&+,+) DISCLAIMERS AND CAUTIONARY STATEMENTS This presentation contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investme ...

The Supreme Cannabis Company, Inc. (SPRWF) Q2 2021 Results Earnings Conference Call February 12, 2021 8:00 AM ET Company Participants Beena Goldenberg - President and Chief Executive Officer Nikhil Handa - Chief Financial Officer Conference Call Participants Andrew Partheniou - Stifel GMP Graeme Kreindler - Eight Capital Rahul Sarugaser - Raymond James Jesse Pytlak - Cormark Securities Operator Good morning, everyone. Welcome to The Supreme Cannabis Company, Inc. Second Quarter 2021 Results Conference Call. ...